Rickettsial and ehrlichial infections
Related Experiment Video
Updated: Jun 16, 2026

An Electroporation Method to Transform Rickettsia spp. with a Fluorescent Protein-Expressing Shuttle Vector in Tick Cell Lines
Published on: October 11, 2022
Carol Glaser1, Laura Christie, Karen C Bloch
1Viral and Rickettsial Disease Laboratory, Richmond, VA, USA. Carol.Glaser@cdph.ca.gov
Abstract:
Rickettsial diseases represent a clinically homogeneous group of infections characterized by fever, headache myalgias, variable presence of a rash, and a broad spectrum of neurological manifestations. Epidemiological information including time of year, geography, history of arthropod exposure, and animal contact gives important clues to the diagnosis, and should be actively elicited. Abnormalities in hematological indices of liver function tests should also increase suspicion for illness. Delay in initiation of doxycycline therapy while awaiting laboratory confirmation of infection has been associated with progressive neurological impairment and death. Clinicians should maintain a low threshold to initiate empiric therapy for rickettsial diseases in any patient with neurological findings and compatible exposures, signs, or laboratories, as these syndromes represent readily treatable causes of neurological dysfunction.
Related Concept Videos
Rocky Mountain Spotted Fever
Intracellular Movement of Viruses and Bacteria
Bacterial Phylum Chlamydiae
Bacterial Phylum Spirochaetes
Respiratory Syncytial Virus Disease
Rabies

